Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1611 1655
This examiner grants 40% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19413266 | Methods and Compositions for Managing and/or Alleviating Symptoms of Muscular Dystrophies and Other Genetic Muscular Disorders | Final Rejection | MYOS CORP. |
| 19340757 | Hair Treatment Compositions | Final Rejection | TMPL 8 Corp |
| 18024949 | ANTI-COCCIDIAL COMPOSITION COMPRISING MANGOSTEEN AND USES THEREOF | Non-Final OA | CJ CHEILJEDANG CORPORATION |
| 18839797 | EMOLLIENT COMPOSITION | Non-Final OA | CARGILL, INCORPORATED |
| 18893955 | METHOD FOR ACTIVATING DENDRITIC CELLS AND METHOD FOR ACTIVATING NATURAL KILLER CELLS, HELPER T CELLS, KILLER T CELLS, B CELLS, OR MACROPHAGES | Non-Final OA | TOYO SHINYAKU CO., LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy